Autopsy report · NCT00868361

A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel

“Poor recruitment of fast and slow acetylators”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 4 months before it stopped.
• 10 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Sponsor type

Industry

Conditions

Healthy

Interventions

Talampanel (non-radiolabeled), [14C] Talampanel

Participants

10 (planned, not actual)

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.